Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy

European Journal of Internal Medicine

Volumn 22, Issue 6, 2011, Pages 621-625

  López Palacios, Natalia ^a   Mendoza, Juan L ^a   Taxonera, Carlos ^a   Lana, Raquel ^a   López Jamar, José Miguel Esteban ^a   Díaz Rubio, Manuel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Azathioprine; Clinical remission; Mercaptopurine; Mucosal healing; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COLON MUCOSA; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTESTINE ENDOSCOPY; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; OPEN STUDY; RELAPSE; TREATMENT DURATION; TREATMENT OUTCOME; ULCER HEALING; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; AZATHIOPRINE; COHORT STUDIES; COLITIS, ULCERATIVE; COLONOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

EID: 80855143586     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.06.017     Document Type: Article

References (28)

1. P. Rutgeerts, S. Vermeire, and G. Van Assche Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut 56 2007 453 455 (Pubitemid 46580492)
2. G. Pineton de Chambrun, L. Peyrin-Biroulet, M. Lémann, and J.F. Colombel Clinical implications of mucosal healing for the management of IBD Nat Rev Gastroenterol Hepatol 7 2010 15 29
3. S. Kane, F. Lu, A. Kornbluth, D. Awais, and P.D. Higgins Controversies in mucosal healing in ulcerative colitis Inflamm Bowel Dis 15 2009 796 800
4. R.M. Cooney, B.F. Warren, D.G. Altman, M.T. Abreu, and S.P. Travis Outcome measurement in clinical trials for ulcerative colitis: towards standardisation Trials 8 2007 17
5. K.F. Froslie, J. Jahnsen, B.A. Moum, M.H. Vatn IBSEN Group Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort Gastroenterology 133 2007 412 422 (Pubitemid 47187355)
6. G.C. Actis, R. Pellicano, E. David, and A. Sapino Azathioprine, mucosal healing in ulcerative colitis, and the chemoprevention of colitic cancer: a clinical-practice-based forecast Inflamm Allergy Drug Targets 9 2010 6 9
7. C. Ha, and A. Kornbluth Mucosal healing in inflammatory bowel disease: where do we stand? Curr Gastroenterol Rep 12 2010 471 478
8. T. Kobayashi, M. Naganuma, S. Okamoto, T. Hisamatsu, N. Inoue, and H. Ichikawa Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis J Gastroenterol 45 2010 1129 1137
9. K. Ohno, Y. Masunaga, R. Ogawa, M. Hashiguchi, and H. Ogata A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis Yakugaku Zasshi 124 2004 555 560 (Pubitemid 41350481)
10. A. Timmer, J.W. McDonald, and J.K. Macdonald Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis Cochrane Database Syst Rev 2007 CD000478
11. J.P. Gisbert, P.M. Linares, A.G. McNicholl, J. Maté, and F. Gomollón Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis Aliment Pharmacol Ther 30 2009 126 137
12. O.A. Paoluzi, R. Pica, A. Marcheggiano, P. Crispino, F. Iacopini, and C. Iannoni Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission Aliment Pharmacol Ther 16 2002 1751 1759
13. S. Ardizzone, G. Maconi, A. Russo, V. Imbesi, E. Colombo, and G. Bianchi Porro Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis Gut 55 2006 47 53 (Pubitemid 41820634)
14. J.E. Lennard-Jones Classification of inflammatory bowel disease Scand J Gastroenterol 1989 2 6 [discussion 16-9] (Pubitemid 20015811)
15. S.C. Truelove, and L.J. Witts Cortisone in ulcerative colitis; final report on a therapeutic trial Br Med J 2 1955 1041 1048
16. K. Schroeder, W.J. Tremaine, and D.M. Ilstrup Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study N Engl J Med 317 1987 1625 1629 (Pubitemid 18010466)
17. M.J. Carter, A.J. Lobo, and S.P. Travis Guidelines for the management of inflammatory bowel disease in adults Gut 53 2004 V1 V16
18. W.J. Sandborn, M.A. Kamm, G.R. Lichtenstein, A. Lyne, T. Butler, and R.E. Joseph MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials Aliment Pharmacol Ther 26 2007 205 215 (Pubitemid 46985493)
19. V. Gross, S. Bar-Meir, A. Lavy, O. Mickisch, Z. Tulassay, and L. Pronai Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis Aliment Pharmacol Ther 23 2006 303 312 (Pubitemid 43382041)
20. P. Rutgeerts, W.J. Sandborn, B.G. Feagan, W. Reinisch, A. Olson, and J. Johanns Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2005 2462 2476 (Pubitemid 41770166)
21. M. Barreiro-de Acosta, A. Lorenzo, and J.E. Dominguez-Muñoz Adalimumab in ulcerative colitis: two cases of mucosal healing and clinical response at two years World J Gastroenterol 15 2009 3814 3816
22. T. Yamamoto, S. Umegae, and K. Matsumoto Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: a prospective cohort study Inflamm Bowel Dis 16 2010 1905 1911
23. J.L. Cabriada, N. Ibargoyen, A. Hernández, A. Bernal, and A. Castiella Sustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: results at 1 year [Bernal A, Castiella A] Dig Liver Dis 42 2010 432 435
24. M.A. Kamm, G.R. Lichtenstein, W.J. Sandborn, S. Schreiber, K. Lees, and K. Barrett Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis Gut 57 2008 893 902 (Pubitemid 351919522)
25. P. Rutgeerts, B.G. Feagan, G.R. Lichtenstein, L.F. Mayer, S. Schreiber, and J.F. Colombel Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease Gastroenterology 126 2004 402 413 (Pubitemid 38182297)
26. R.B. Gupta, N. Harpaz, S. Itzkowitz, S. Hossain, S. Matula, and A. Kornbluth Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study Gastroenterology 133 2007 1099 1105 [quiz 1340-1] (Pubitemid 47494461)
27. G. D'Haens, W.J. Sandborn, B.G. Feagan, K. Geboes, S.B. Hanauer, and E.J. Irvine A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis Gastroenterology 132 2007 763 786
28. J. Powell-Tuck, D.W. Day, N.A. Buckell, J. Wadsworh, and J.E. Lennard-Jones Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis Dig Dis Sci 27 1982 533 537 (Pubitemid 12120288)